Why nanobusiness needs nanoethics: lessons from the European GMO
food debacle
Nigel M. de
S. Cameron
Institute on Biotechnology and the Human Future,
Illinois
Institute of Technology
Chicago, IL 60661 USA
As the bright prospects for nanoscale research begin to lead to
applications in many products and sectors of the economy, there is
still very limited public awareness of the technology and its
potential applications. This lies in contrast with Europe, where
there has traditionally been a more critical approach to new
technologies and therefore earlier awareness of their development.
In voting
almost a billion dollars for nanoscale funding in the 21st Century
Nanotechnology Research and Development Act, the US Congress has
determined that "ethical, legal, societal and environmental"
research is a key part of the package. The ethical and social issues
at stake are many, but chief among them lie issues of safety, and
what Mike Roco, who heads the National Nanotechnology Initiative at
the NSF (the lead funding agency), recently described as "respect
for the human condition." It is this combination of safety concerns
(which have led Swiss Re, for example, the world's second largest
re-insurer, to raise fundamental problems about the proper
assessment of nanoscale risk, and draw parallels with asbestos), and
concerns about the impact of this technology - in combination with
others - on "the human condition," that give raise to major
uncertainty in respect of public acceptance.
This is not
the only reason for focus on ethical and social issues, which in the
context of public policy are important in themselves. And there are
special reasons that help account for the European GMO food debacle.
Yet it offers a classic example of the importance of early and
transparent discussion of social and ethical issues raised by
technology, as well as prudent approaches to risk. While this may
seem to raise needless hurdles to successful research and
development in the early stages of the technology itself and of
individual product development, the enduring lesson of the European
GMO story is that without such a process there is always the
possibility of a highly effective technology that has all the
trappings of success with the exception of a market.
|